Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Ritter

Showing results (191-200 of 195) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 195 results.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2022
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinomaNiklas Klümper, Danijel Sikic, Jonas Saal, et al.
BMC Cancer|May 11, 2021
No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in GermanyRoman Rüdiger, Franziska Geiser, Manuel Ritter, et al.
Trials|November 13, 2024
PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trialRouvier Al-Monajjed, Peter Albers, Johanna Droop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin ResistanceNiklas Klümper, Damian J Ralser, Jörg Ellinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2024
<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial CancerNiklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, et al.
Pageof 20

Showing results (191-200 of 195) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 195 results.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2022
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinomaNiklas Klümper, Danijel Sikic, Jonas Saal, et al.
BMC Cancer|May 11, 2021
No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in GermanyRoman Rüdiger, Franziska Geiser, Manuel Ritter, et al.
Trials|November 13, 2024
PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trialRouvier Al-Monajjed, Peter Albers, Johanna Droop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin ResistanceNiklas Klümper, Damian J Ralser, Jörg Ellinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2024
<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial CancerNiklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, et al.
Pageof 20